Long COVID care pathways: a systematic review
Wolf S, Erdos J
Record ID 32018001717
Authors' objectives: Due to the expected growing number of cases and the associated increasing average sick leave durations, long COVID not only places a burden on the patients and their families but also the wider economy, in particular, the workforce. The present systematic review aimed to support preparations and adjustments in the long COVID care planning in Austria by giving (1) an overview of recommendations about long COVID care pathways for adult patients as well as (2) examples of already existing care structures in selected European countries.
Authors' results and conclusions: In the included literature, it was recommended that the majority of long COVID-related healthcare should take place in primary care. There are however some differences in the served patient groups between countries. While, for example, in Austria and Germany, all long COVID patients -including former hospitalised and non-hospitalised COVID-19 patients- are advised to consult the general practitioner for a first clinical assessment, in the United Kingdom former hospitalised COVID-19 patients, who suffer from ongoing or new symptoms after 12 weeks of discharge, can attend primary care facilities or secondary care outpatient departments. After the first assessments, patients with more complex symptoms are advised to be referred to so-called specialised long COVID outpatient assessment clinics for further assessments. Some clinics are also intended to offer treatments, such as rehabilitative elements, themselves. Patients with one dominant symptom are recommended to be referred to secondary assessment by the respective specialist. Further options include rehabilitation, community health services and non-medical healthcare providers and are chosen depending on the patients' needs. Furthermore, self-management, such as exercising at home or stress reduction, is recommended as a single therapy for milder long COVID symptoms or as a supporting therapy in addition to other treatments for moderate to severe symptoms. In the United Kingdom, doctors can also refer the patients to a supported self-management online programme "The Your COVID Recovery Platform". Concerning additional (social) services, the same services as for other (chronic) diseases are also recommended for long COVID patients including support for employees, such as sick leave, phased return or transitional allowance.
Authors' recomendations: Overall, multidisciplinarity, a personalised approach and shared decision-making have been named as key factors for successful long COVID care. For that matter, good communication between healthcare professionals and the patients, including inclusive communication (e.g. by offering translated materials) and the right balance in the detail of provided information to avoid unnecessary uncertainty, is crucial.
Authors' methods: A systematic search in four databases and further unsystematic hand searches were conducted. Based on the predefined inclusion criteria, in total 14 references including five guidelines, four reviews, one consensus paper and four clinical perspectives were included for answering both research questions. To answer the second research question, an additional 23 references from further hand searches and expert consultations were considered including websites about patient organisations, healthcare facilities, social care services and a newspaper article about relevant healthcare facilities.
Project Status: Completed
URL for project: https://aihta.at/page/spaet-und-langzeitfolgen-nach-einer-sars-cov-2-erkrankung-update/en
Year Published: 2021
URL for published report: https://eprints.aihta.at/1342/7/HTA-Projektbericht_Nr.135b.pdf
URL for additional information: https://eprints.aihta.at/1342/
English language abstract: An English language summary is available
Publication Type: Full HTA
- Olfactory Perception
- Neurocognitive Disorders
- Coronavirus Infections
- Long COVID
- care pathways
- existing care structures
Organisation Name: Austrian Institute for Health Technology Assessment
Contact Address: Garnisongasse 7/20, A-1090 Vienna, Austria
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: HTA Austria - AIHTA GmbH
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.